Correlation Between Adagene and Cerevel Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Adagene and Cerevel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adagene and Cerevel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adagene and Cerevel Therapeutics Holdings, you can compare the effects of market volatilities on Adagene and Cerevel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adagene with a short position of Cerevel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adagene and Cerevel Therapeutics.

Diversification Opportunities for Adagene and Cerevel Therapeutics

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Adagene and Cerevel is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Adagene and Cerevel Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cerevel Therapeutics and Adagene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adagene are associated (or correlated) with Cerevel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cerevel Therapeutics has no effect on the direction of Adagene i.e., Adagene and Cerevel Therapeutics go up and down completely randomly.

Pair Corralation between Adagene and Cerevel Therapeutics

Given the investment horizon of 90 days Adagene is expected to generate 1.01 times more return on investment than Cerevel Therapeutics. However, Adagene is 1.01 times more volatile than Cerevel Therapeutics Holdings. It trades about 0.05 of its potential returns per unit of risk. Cerevel Therapeutics Holdings is currently generating about -0.03 per unit of risk. If you would invest  133.00  in Adagene on August 27, 2024 and sell it today you would earn a total of  86.00  from holding Adagene or generate 64.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy78.55%
ValuesDaily Returns

Adagene  vs.  Cerevel Therapeutics Holdings

 Performance 
       Timeline  
Adagene 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Adagene has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Cerevel Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cerevel Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Cerevel Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Adagene and Cerevel Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Adagene and Cerevel Therapeutics

The main advantage of trading using opposite Adagene and Cerevel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adagene position performs unexpectedly, Cerevel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cerevel Therapeutics will offset losses from the drop in Cerevel Therapeutics' long position.
The idea behind Adagene and Cerevel Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets